DearingW. H.HeilmanF. R. (1953). Micrococcic (staphylococcic) enteritis as a complication of antibiotic therapy; its response to erythromycin. Proc. Staff. Meet. Mayo Clinic, 28, 121.
2.
DowlingH. F.LepperM. H.JacksonG. G. (1955). Clinical significance of antibioticresistant bacteria. J. Amer. med. Ass., 157, 327.
3.
FiskA. (1940). The technique or the coagulase test for staphylococci. Brit. J. exp. Path., 21, 311.
4.
ForfarJ. O.MaccabeA. F.BalfC. L.WrightH. A.GouldJ. C. (1955). Staphylococcal infection in the new-born treated with erythromycin. Lancet, 1, 584.
5.
GouldJ. C.AllanW. S. A. (1954). Staphylococcus pyogenes cross-infection: Prevention by treatment of carriers. Lancet, 2, 988.
6.
GouldJ. C.BowieJ. H. (1952). The determination of bacterial sensitivity to antibiotics. Edin. med. J., 59, 178.
7.
GouldJ. C. (1955). The effect of local antibiotic on nasal carriage of Staph, pyogenes. J. Hyg. (Camb.), 53, 379.
8.
MargaretE. GrigsbyChappelleE.PeacockT. (1955). Erythromycin sensitivity of M. pyogenes var aureus in a hospital population (development of resistance). Antibiotics and chemotherapy, 5, 350.
9.
HobsonD. (1954). Activity of erythromycin against Staph, pyogenes. Brit. med. J., 1, 236.
10.
Leading Article (1956). Restriction of antibiotics. Lancet, Jan. 28th, p. 193.
11.
LepperM. H.MoultonB.DowlingH. F.JacksonG. G.KormanS. (1953). Epidemiology of erythromycin-resistant staphylococci in a hospital population; effect on therapeutic activity of erythromycin. Antibiotics Annual, 1953–54. New YorkMedical Encyclopaedia Inc., p. 308.
12.
McGuireJ. M.BunchR. L.AndersonR. C.BoazH. E.FlynnE. H.PowellN. M.SmithJ. W. (1952). ‘Ilotycin’, a new antibiotic. Antibiotics and chemotherapy, 2, 281.
